Adsorption of poloxamine 908, a tetrafunctional polyethylene oxide (PEO)-polypropylene oxide ethylenediamine block copolymer, onto the surface of monodispersed polystyrene nanoparticles (232 ± 0 33 nm) follows a bimodal pattern. Initially, the isotherm follows a Langmuir profile with a plateau observable over a very narrow equilibrium poloxamine concentration (0.0018-0.0031 mM). The isotherm then begins to rise again, reaching a final plateau at equilibrium poloxamine concentrations above 0.0089 mM. Similarly, the profile of the adsorbed layer thickness of poloxamine on the surface of nanoparticles is bimodal. The first plateau corresponds to a thickness of 4 6 ± 0 07 nm, which occurs over the same range of poloxamine concentrations as in the initial plateau of the adsorption isotherm. The second plateau corresponds to a thickness of 9 53 ± 0 32 nm, observable at a minimum poloxamine concentration of 0.0067 mM. By using a calculated radius of gyration of a PEO chain in poloxamine as 3.1 nm, these observations reflect dynamic changes in the arrangement of surface projected PEO chains; a mushroom-like conformation at the first plateau region of the adsorption isotherm, followed by a transition into a brush-like conformation. These conformational changes are also reflected in rheological studies; the apparent viscosity of nanoparticles in which the PEO chains are in mushroom conformation is considerably higher than particles displaying the brush conformation. Further, atomic force microscopy studies (height profile and phase lag measurements) corroborated that the proposed poloxamine concentration dependent transition of surface associated PEO chains from mushroom to brush appearance is conserved when nanoparticles are dried under ambient conditions. Finally, we compared the influence of the surface PEO characteristics on complement consumption in human serum. Our results show complement-activating nature of all poloxamine-coated nanoparticles. However, complement consumption is reduced substantially with particles bearing a minimum of 11448 poloxamine molecules on their surface, thus demonstrating the importance of PEO surface density as well as brush conformation in suppressing complement consumption. This relationship between surface characteristics of poloxamine nanoparticles and their in vivo performance is discussed.
INTRODUCTION
The clearance rate and body distribution of intravenously and subcutaneously injected model polystyrene nanoparticles is altered dramatically by surface modification with poloxamine 908, a nonionic block copolymer of propylene oxide and ethylene oxide. [1] [2] [3] [4] For instance, surface modification of particles of 150 nm and below in diameter with poloxamine 908 generates entities that are resistant to recognition and clearance by quiescent hepatic * Author to whom correspondence should be addressed.
Kupffer cells when injected intravenously. [5] [6] [7] Such surfacemodified particles exhibit prolonged circulation times in the systemic circulation but their blood residency time is controlled by the extent of poloxamine shedding, and hence the loss of the steric barrier, from their surface. For larger particles (150-300 nm), surface decoration with poloxamine 908 not only prolongs their circulatory profile, but simultaneously triggers nanoparticle filtration at interendothelial cell slits (IECS), which are located at the walls of splenic venous sinuses; these nanoparticles have served as a model for development of biodegradable splenotropic entities.
Recently, it has become apparent that the conformational state of surface projected hydrophilic polymers or polyethyleneoxide (PEO) chains of poloxamers and poloxamines modulates the biological performance of nanoparticles. [11] [12] [13] [14] [15] For example, nanoparticles with surface exposed PEO chains or methoxy(polyethylene glycol) 2000−5000 in a predominantly "mushroom-brush" or "brush" conformation are resistant to opsonization and recognition by quiescent macrophages both in vitro and in vivo, whereas particles bearing the polymers in a "non-overlapped mushroom" display are susceptible to protein adsorption, opsonization, and ingestion by phagocytic cells. [14] [15] [16] With respect to poloxamers and poloxamines, previous adsorption isotherm studies have failed to demonstrate the proposed concentration dependent structural ordering and conformational transition of PEO chains on the surface of nanoparticles, presumably due to the lack of sensitive assay procedures for quantitative determination of bulk copolymer concentration. 11 17-20 Therefore, we have re-evaluated the adsorption characteristics of poloxamine 908 onto polystyrene nanoparticles as a function of bulk copolymer concentration with a highly sensitive colorimetric assay. For the first time, we demonstrate a bimodal adsorption isotherm for poloxamine 908, thus reflecting the dynamic changes in the arrangements of projected PEO chains. These features are further supported by photon correlation spectroscopy, rheological investigations, atomic force microscopy, and complement consumption studies.
MATERIALS AND METHODS

Adsorption Isotherm Studies
Polystyrene nanoparticles (2.5% w/v), 232 ± 0 33 nm in diameter, manufactured by Polysciences Inc. (USA), were purchased from Park Scientific (Northampton, UK). Poloxamine 908 was a kind gift of BASF Aktiengesellschaft (Ludwigshafen, Germany) and used without further modification. Poloxamine 908 (Mw = 22 455; Mn = 13 220; Mz = 28 190) solutions were prepared in 10 mM McIlvaine buffer (pH 7.2). Poloxamine-coated particles were prepared in triplicate by adding 1.25 mg of polystyrene nanoparticles (corresponding to 1 893 × 10 11 particles and a total surface area of 0.032 m 2 ,) to poloxamine solutions ranging from 0 to 400 g/ml poloxamine (0-0.0178 mM) in a total volume of 1.0 ml in Eppendorf tubes. All tubes were shaken gently (100 rpm) for 24 h at 25 C in a water bath. The suspensions were then centrifuged for 40 min at 16 000 × g. No polystyrene particles were lost in supernatants as monitored by light scattering during the centrifugation steps. Poloxamine concentrations were determined by a biphasic colorimetric assay 21 for the resulting supernatants using a standard curve run concurrently with the adsorption experiment (control tubes without any polystyrene particles but containing the same concentrations of poloxamine as in adsorption isotherm).
For the colorimetric assay, aliquots (in a total volume of 0.5 ml) of standard poloxamine solutions (in McIlvaine buffer, pH 7.2) or supernatants from the adsorption isotherm were added to Eppendorf tubes containing 0.5 ml chloroform and 0.5 ml reagent solution (400 mM ammonium thiocyanate and 100 mM anhydrous ferric chloride). The system was then mixed vigorously for 20 minutes at room temperature to attain equilibrium, followed by centrifugation (3 min) using a microfuge at 16 000 × g. The lower chloroform layer was extracted, transferred to a quartz cuvette with 1 cm path length, and covered with a small volume of the reagent solution. The absorbance was measured at 510 nm using a Helios Unicam Spectrophotometer (Spectronic Unicam, UK).
The adsorption isotherm of bovine serum albumin on polystyrene lattices was also constructed as described in detail previously. 14 
Particle Size and Electrophoretic Mobility
The hydrodynamic radius and the electrophoretic mobility of particles were determined by photon correlation spectroscopy (PCS) and laser Doppler electrophoresis, respectively, in 10 mM McIlvaine buffer, pH 7.2, at 25 C using a Zetasizer 3000 system (Malvern Instruments, UK) as described previously.
14 PCS measurements (based on CONTIN analysis) were determined at a wavelength of 633 nm, scattering angle of 90 , dispersant viscosity of 0.89 cP and refractive index of 1.35, respectively. For electrophoretic mobility measurements the conditions were as follows: dielectric constant 78.3, current 1.4 mA, fluid refractive index of 1.35, cell field of 29.3 V/cm, viscosity of 0.89 cP and conductivity of 0.7 mS/cm.
Viscosity Measurements
The viscosity of poloxamine 908 in 10 mM McIlvaine buffer, pH 7.2, (2 mg poloxamine/ml), water, the buffer solution and nanoparticle suspensions (volume fraction = 0 18), was measured at 25 ± 0 1 C using a Thermo Haake RheoStress 1 rheometer (Gebrüder HAAKE GmbH, Germany). A C30 cone-plate sensor system with 1 angle and a gap of 0.054 mm was used. Poloxaminecoated nanoparticles were free from unbound poloxamine molecules. The viscosity (apparent) was obtained from the slope of linear part (from 8 to 16 s −1 ) of the shear strain versus shear rate plot. An oscillation test was also performed with nanoparticle suspensions at a constant frequency of 1 Hz and strain of 0.05-20. Each test was repeated three times. Data analysis was carried out with the Thermo Haake software RheoWin Pro.
Scanning Electron Microscopy (SEM) and Atomic Force Microscopy (AFM)
The surfaces of aluminium pin stubs (1.2 cm) were covered with double adhesive carbon tabs (Agar Scientific Ltd., UK) and used for sample placement. Uncoated and poloxamine-coated nanoparticles (50 l, corresponding to 1 9 × 10 11 particles) were placed on the carbon base and allowed to dry. Poloxamine-coated nanoparticles were free from unbound poloxamine molecules. Samples were then treated with palladium (2 nm) and visualized at 5 keV using a Joel 6310 scanning electron microscope (Joel, Welwyn Garden City, UK). For AFM studies, purposebuilt steel stubs were used and their surface was covered with double adhesive carbon tabs prior to the sample placement. Nanoparticle suspensions (1 9 × 10 11 particles) were then placed on the carbon base and allowed to dry at 25 C and 55% relative humidity. Samples were analysed by AFM using a Digital Instruments Nanoscope (Digital Instruments, Cambridge, UK) in tapping mode with a multimode SPM head under ambient conditions. For scanning a silicon cantilever resonating at 295 kHz was used at a scan rate of 0.7 Hz. Vertical height and phase lag analysis were then carried out. 23 24 The phase lag (expressed in degrees) measures the effective damping of the instrument driven tapping motion of the cantilever as a feedback signal and is a reflection of the material nature of the surface.
Residual Total Complement Haemolytic Assay
Freshly obtained human serum was diluted 1 : 5 with isotonic veronal buffered saline (containing 0.5 mM MgCl 2 , 0.15 mM CaCl 2 and 0.1% w/v gelatin). Diluted human serum (100 L) was incubated with 50 l of nanoparticle suspension (0.5 mg polystyrene) at 37 C for 1 h in Eppendorf tubes. After the incubation period, the mixtures were diluted with 850 L of ice cold isotonic veronal buffered saline and particles were pelleted by centrifugation at 4 C. Residual total complement haemolytic activity of particle-treated serum was measured according to established methods.
14 Briefly, sheep erythrocytes were sensitized with rabbit anti-sheep erythrocyte antibody and suspended to 1 5 × 10 8 cells/mL in isotonic veronal buffered saline. Triplicate aliquots of 50 L antibody sensitized cells were incubated with 500 L of particle-treated serum for 30 min at 37 C. Thus, the final serum dilution was 55-fold and within the effective dynamic range of the CH 50 assay. Reactions were then stopped by the addition of 2 mL of dextrose-gelatin veronal-buffered saline containing 40 mM EDTA. Unlysed erythrocytes were pelleted by centrifugation and the amount of haemoglobin released into the supernatant was quantified spectrophotometrically at 414 nm. Blanks and 100% lysis controls were also performed. The residual complement haemolytic activity was also assessed in heat treated serum (56 C, 30 min) as well as zymosan-treated serum. The residual complement haemolytic activity of the treated serum is expressed as a percentage of the total haemolytic level as determined in the 100% lysis control.
RESULTS AND DISCUSSION
Adsorption Isotherm and Surface Characteristics of Adsorbed Poloxamine Molecules
The adsorption of poloxamine 908 onto polystyrene nanoparticles (156 nm) was studied previously 17 where a Langmuir type adsorption was recorded with a plateau value of 0 084±0 074 mol poloxamine/m 2 . In agreement with this study, the results in Figure 1a demonstrate that poloxamine 908 has a high affinity for the surface of polystyrene nanoparticles (232 nm) at low concentrations. However, in contrast to the previously reported observations 17 the isotherm is bimodal. Initially, the isotherm follows the Langmuir profile; after an initial sharp increase, the isotherm breaks at approximately 0 0379 ± 0 0004 mol/m 2 . This plateau is observable over a very narrow equilibrium poloxamine concentration (0.0018-0.0031 mM, corresponding to 40-70 g/ml); the isotherm then begins to rise again and finally reaches a plateau limit in the region of 0 1124 ± 0 0213 mol/m 2 . All features of this isotherm have been confirmed by repeated experiments. From the quantitative point of view, the discrepancies between the current study and that of the previous study 17 are most likely to arise from differences in sensitivity of the techniques used for determination of the residual concentration of poloxamine in the supernatant following nanoparticle sedimentation. We have used a highly reproducible and a sensitive biphasic colorimetric assay capable of determining poloxamine 908 concentrations as low as 10 g/ml. 21 The sensitivity of the refractometric measurements as reported in the previous work 17 for determination of low concentrations of poloxamine 908 is questionable and this could lead to underestimation of adsorbed copolymer quantities on to the surface of nanoparticles. However, we can not disregard possible differences in the surface properties of the polystyrene lattices as well as differences in the polydispersity of the poloxamine 908 used in the two studies, which may account for discrepancies in the adsorbed quantities at the final plateau region. Nevertheless, this is the first demonstration for bimodal adsorption behaviour of a tetrafunctional PEO-PPO ethylenediamine block copolymer on polystyrene lattices. We therefore recommend re-evaluation of adsorption isotherms with other related PEO-PPO based block copolymers with sensitive assays such as the one used here.
The bimodal feature of the adsorption isotherm may reflect dynamic changes in the arrangements of PEO, and to some extent PPO, chains of the adsorbed poloxamine molecules. To investigate this, the hydrodynamic radii of nanoparticles were measured by PCS. The results in Figure 1b demonstrate a dramatic increase in nanoparticle size following poloxamine 908 adsorption at all points on the adsorption isotherm. The results clearly show that the adsorbed layer thickness of poloxamine on the nanoparticle surface is dependent on initial copolymer concentration. It is noteworthy that changes in the nanoparticle size, which is a reflection of the adsorbed layer thickness of poloxamine on the nanoparticle surface, follow a similar pattern to the adsorption isotherm. Following an initial sharp increase, the adsorbed layer thickness of poloxamine 908 reaches an initial plateau region, 4 60 ± 0 07 nm, and is maintained over the equilibrium copolymer concentration of 0.0018-0.0031 mM. Afterwards, nanoparticle size increases sharply with increasing bulk poloxamine concentration and eventually reaches a final plateau corresponding to an adsorbed layer thickness of 9 53 ± 0 32 nm (Table I ). Considering the fact that the number of adsorbed poloxamine molecule per sphere is approximately 3-fold higher at the top plateau when compared to the first plateau region (Fig. 1c and Table I ), changes in hydrodynamic radii suggest an altered conformation of adsorbed poloxamine molecules. Indeed, this transition in conformational change is apparent from equilibrium polymer concentrations of 0.0067 mM (point D), Figure 1b . Although at concentrations corresponding to the top plateau of the adsorption isotherm more poloxamine molecules are accommodated on to the surface of nanoparticles than that of point D (approximately 1.7-fold increase), Figure 1c , the hydrodynamic radii of nanoparticles remain the same (Fig. 1b) . If the PEO chains of poloxamine 908 in the adsorbed layer assume a random coil conformation, and by using a calculated radius of gyration (R g ) of a PEO chain in poloxamine 908 as 3.1 nm, 22 then the estimated adsorbed layer thickness at the final plateau of the adsorption isotherm should be approximately 6.2 nm (2R g ). However, this is based on an assumption that the contribution of the PPO region to the adsorbed layer thickness is negligible, although it is very likely that the PPO chain will assume a loop and trail conformation at the particle surface. At equilibrium poloxamine concentrations corresponding up to the first plateau region on the adsorption isotherm, the measured hydrodynamic Table I . Physicochemical characteristics of poloxamine 908-coated nanoparticles at both plateau regions of the adsorption isotherm at room temperature. thickness layers are, indeed, lower than 2R g for the corresponding PEO chains. This presumably implies that PEO chains are spread laterally with portions in close contact with the surface of the nanoparticles (mushroom conformation); here an average surface area of 45 6 ± 2 0 nm 2 is available per poloxamine molecule ( Fig. 1d and Table I ). At concentrations immediately above the first plateau region, the hydrodynamic radius exceeds 2R g for the corresponding PEO chains (Fig. 1b) . This is due to surface crowding with poloxamine 908 molecules where the average available surface area per adsorbed molecule is 25 3 ± 0 5 and 14 1 ± 0 7 nm 2 for point D and the top plateau region, respectively. Therefore, this indicates a laterally compressed elongated random coil conformation for projected PEO chains in a direction perpendicular to the plane of particle surface (brush conformation); such conformational states are achievable with a minimum of approximately 6600 poloxamine molecules (corresponding to point D on the adsorption isotherm) on the used curvature. Indeed, the proposed transition from mushroom to brush conformation for PEO chains of adsorbed block copolymers on nanoparticle surfaces has been speculated by others in the past, but this was never demonstrated on the corresponding adsorption isotherms.
11 17 19 20 This is most likely due to the fact that the first adsorption plateau, corresponding to the mushroom conformation, occurs over a narrow range of equilibrium copolymer concentrations. This requires a sensitive assay procedure for quantitative determination of bulk poloxamine concentration, and therefore escaped attention in previous studies.
Rheological Characterization of Nanoparticles
To further elaborate on the PEO surface conformation, rheological studies were conducted. The results in Figure 2 show the apparent viscosity of uncoated as well as poloxamine-coated nanoparticle dispersions with a volume fraction of 0.18 at room temperature. The apparent viscosity of uncoated nanoparticles was 2 2 ± 0 3 mPas, whereas those for poloxamine-coated particles were considerably higher. Notably, the apparent viscosity of particles precoated with poloxamine 908 at a concentration below (point B) or at the first plateau region (point C) of the adsorption isotherm was approximately 10-and 15-fold higher than that of uncoated nanoparticles. This trend of increase in the apparent viscosity is presumably due to entangling and interpenetration of laterally spread PEO chains between adjacent nanoparticle surfaces following collision at very low shear rates. Interestingly, the apparent viscosity values dropped dramatically with particles bearing higher amounts of poloxamine 908 (e.g., such as those corresponding to points D and E on the adsorption isotherm), but remained significantly higher than that of uncoated nanoparticles. Among the coated particles, those from the top plateau region of the adsorption isotherm (E) exhibited the lowest apparent viscosity values. These observations indicate that under low shear conditions PEO chain-chain interaction and entanglement arising from particle-particle collision is poor in comparison (a "spring-like" surface behaviour), and therefore is a reflection of the altered PEO chain conformation (brush) at the nanoparticle surface. Dynamic (oscillatory) measurements at a constant frequency of 1 Hz with gradual increase in strain amplitude (up to 20 Pa) further confirmed the absence of network formation or significant aggregation in all nanoparticle dispersions with the phase volume of 0.18 (data not shown). As a positive control, significant networking was detected with nanoparticles coated with a monolayer of bovine serum albumin molecules, which arises from protein-protein interaction (data not shown).
SEM and AFM Observations
Next, we examined the effect of the polymer conformation on the packing arrangement of nanoparticles with SEM on a graphite base. Uncoated nanospheres aggregate in an unstructured way (Fig. 3) . In contrast, nanospheres tend to form regular arrangements on the graphite base when coated with poloxamine 908 to the level of the first plateau of the adsorption isotherm (Fig. 2, Type B & C) . However, the packing arrangement is most regular when the available surface area is 44 nm 2 per poloxamine molecule (Fig. 2, Type C) . As the amount of poloxamine is increased towards the second plateau, it appears that subsequent layers form a three-dimensional close-packed array (Fig. 2 Fig. 3 . Scanning electron micrographs of uncoated and poloxamine 908-coated nanoparticles. The uncoated nanospheres are referred to as type A and poloxamine-coated nanospheres (types B-E) refer to selected points on the adsorption isotherm (see legend to the Fig. 1 ).
the ether oxygen atoms. In order to assess whether the presumed configurations of PEO chains on the nanoparticle surface are conserved in the "dry" state, AFM studies were conducted under controlled ambient conditions (25 C and relative humidity of 55%). The results in Figure 4 show height and phase lag measurements for more than 10 images, with more than 30 nanoparticles. The height Distance from particle centre (nm) (f) Fig. 4 . Numerical analysis of AFM images of uncoated and poloxamine 908-coated nanospheres at both plateau regions of the adsorption isotherm. Panels (a-c) represent surface height measurements (in nm) of uncoated and poloxamine-coated nanospheres at points C and E on the adsorption isotherm (see Fig. 1a ), respectively. Panels (d-f) represent corresponding phase lag measurements (degrees) for panels (a-c), respectively. All measurements were undertaken at 25 C and 55% relative humidity. The shaded regions ( , , and ) refer to direct, minor slip, and glancing contact between the AFM probe and nanoparticle surface, respectively. In most cases error bars are embedded within the symbols.
profile for both uncoated and poloxamine-coated particles in reference to the first plateau of the adsorption isotherm (Figs. 4a and b) show a very clear boundary at 100-110 nm and 110 nm, respectively (marked as the region). In comparison, the height profile for poloxamine-coated particles corresponding to the top plateau region of the adsorption isotherm show an indistinct gradual transition from the top to the side with no clear cut boundary (Fig. 4c) . Further, the phase lag data, which is sensitive to variation in material properties of the surface such as hardness, adhesion, friction, and viscoelasticity, 24 is distinctly different between the three samples (Fig. 3d, e, f) . A phase lag of 40-90 is indicative of a hard or a signal dampingtype surface, whereas a phase lag of 0-15 refers to an elastic signal from the probed surface. The phase lag profile for uncoated nanoparticles show a clear change from high to low (from vertical to glancing contact) representing the hard nature of the surface (Fig. 3d) . For coated particles, corresponding to the first plateau of the adsorption isotherm, the phase lag changes from low to high, thus indicating a relatively softer surface with some degree of elasticity, presumably arising from the laterally spread poloxamine molecules (Fig. 3e) . Since, the particle boundary is still clear at 110-120 nm, poloxamine molecules most likely assume a diffuse non-entangled arrangement at the particle surface. Interestingly, for coated particles at the top plateau of the adsorption isotherm, the phase lag profile is far more diffuse and approaches linearity as the surface is probed from the centre to the edge, suggesting a soft and compressible surface. Such elastic properties may represent an altered surface arrangement for PEO chains (a brush like appearance) between adjacent nanoparticles; loading more polymer on to the surface would only change the damping of the probe tip oscillation, which should generate a sharper sigmoid profile in phase lag. These observations therefore tend to corroborate that the proposed poloxamine concentration-dependent transition of surface associated PEO chains from mushroom-like to brush-like appearance is conserved when nanoparticle suspensions are dried under ambient conditions.
Complement Consumption and Relations to Biological Behaviour
Finally, we compared the relationship between the physicochemical characteristics of the poloxamine nanoparticles to their biological performance. We particularly focused on the influence of PEO chain conformation on activation of the human complement system using an established complement haemolytic assay. Human serum was therefore incubated with nanoparticles at 37 C and the residual complement haemolytic activity was quantified; a reduction in the residual complement haemolytic activity of serum signifies activation of the complement system by nanoparticles. The detection of this reduction is sensitive to the initial levels of complement present in serum, which can be optimized by serum dilution. In the present case, optimization was achieved with a 1 : 5 diluted serum prior to nanoparticle addition; this represented a final dilution of 55-fold within the effective dynamic range of the CH 50 haemolytic assay. The results in Figure 5 show that the residual complement haemolytic activity of human serum exposed to nanoparticles coated with poloxamine to the level of the first plateau (types B and C) in the adsorption isotherm is similar to that of uncoated nanoparticles. This indicated an inherent complement-activating nature of uncoated as well as the poloxamine-coated nanoparticles in which the PEO chains are in a mushroom conformation. However, as the amount of polymer was increased towards the second plateau, the residual complement haemolytic activity of serum also increased dramatically (e. g., type D) with nearly 95% activity in the case of coated particles representing the top plateau region of the adsorption isotherm (type E), Figure 5 . In control experiments, free poloxamine, at a concentration corresponding to the adsorbed amount at the top plateau in the adsorption isotherm, failed to affect the haemolytic activity of the diluted serum (data not shown). Therefore, to effectively suppress complement activation, the surface of polystyrene nanoparticles must be enriched with a sufficiently high density of PEO chains in a predominantly brush-like conformation (type E as opposed to type D). It is likely that the characteristics of the described PEO barrier either sterically suppresses or excludes the deposition of large molecules such as IgG, IgM, C1q, and convertases (for instance, the convertase C3bBb has dimensions of 14 × 8 nm) onto the nanoparticle surface, or even interfere with spatial organization of the bound antibodies. The above observations also support the notion that nanoparticles coated with poloxamine 908 (at concentrations equal to or higher than those that correspond to the top plateau region of the adsorption isotherm) are resistant to blood opsonization processes, and therefore exhibit prolonged circulatory profiles in the vasculature. However, splenic filtration of rigid long-circulating nanoparticles at IECS is predominant, providing that the nanoparticle size exceeds the width of the cell slits (particles larger than 200 nm). 1 8-10 This provides efficient access to splenic red pulp and marginal zone compartment for drug and antigen delivery with minimum hepatic sequestration. Earlier, we demonstrated efficient filtration of poloxamine 908-coated polystyrene nanoparticles at IECS, but within a few hours of filtration resident red pulp and marginal zone macrophages phagocytosed filtered nanoparticles. 9 This was a surprising observation, since poloxamine-coated nanoparticles were expected to resist ingestion by quiescent macrophages. The phagocytic process must have occurred after intrasplenic loss of some surface adsorbed poloxamine molecules thus triggering local opsonization events at the nanoparticle surface. Indeed, our results in Figure 5 support this speculation and show significant levels of complement activation with nanoparticles bearing 6000-7000 surface-adsorbed poloxamine molecules with projected PEO chains in a brush conformation (point D).
The circulatory half-life of polystyrene nanoparticles can also be prolonged following adsorption of the linear PEO-PPO-PEO block copolymer poloxamer 407. 11 This copolymer bears the same total number of propylene oxide units as poloxamine 908, but each of its PEO chains is comprised of 98 ethylene oxide units rather than 119 as in the case of poloxamine 908. Further, pharmacokinetic and body distribution of polystyrene nanoparticles (60 and 220 nm in diameter) coated with either copolymers (at the top plateau regions of their respective adsorption isotherms) are very similar. 1 Recently, it was suggested that 25% surface coverage of polystyrene nanospheres (below 100 nm in size) with poloxamer 407 is sufficient to induce long circulating behaviour (with an adsorbed layer thickness of 4.03 nm) or generate "splenotropic" entities with larger particles. 11 However, the calculated 2R g for PEO chains in poloxamer 407 is 5.7 nm. 22 Thus, 25% surface coverage with poloxamer 407, with a corresponding thickness layer of 4.03 nm, could represent the first plateau region of the adsorption isotherm, where the projected PEO chains assume a predominantly mushroom or mushroom-brush intermediate conformation. These surface characteristics may initiate massive complement activation. If we assume that the steric barrier of PEO chains can still interfere with the binding of complement opsonized poloxamer-coated nanoparticles to macrophage complement receptors and renders particles long circulatory, a second consequence of complement activation is rapid generation of anaphylatoxins C3a and C5a leading to the release of thromboxane A2 and possible pseudoallergic reactions. 16 Therefore, the presence of a high PEO surface density (or at least 90% surface coverage) is necessary in order to minimize the initiation of untoward immunological reactions at injection time.
